Hemodynamics and early clinical performance of the St. Jude Medical Regent mechanical aortic valve |
| |
Authors: | Bach David S Sakwa Marc P Goldbach Martin Petracek Michael R Emery Robert W Mohr Friedrich W |
| |
Institution: | a Department of Medicine, Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA b Section of Cardiothoracic Surgery, Department of Surgery, William Beaumont Hospital, Royal Oak, Michigan, USA c Section of Cardiothoracic Surgery, Department of Surgery, London Health Sciences Center, London, Ontario, Canada d Section of Cardiothoracic Surgery, Department of Surgery, St. Thomas Hospital, Nashville, Tennessee, USA e Section of Cardiothoracic Surgery, Department of Surgery, Herzzentrum Universitat Leipzig, Leipzig, Germany |
| |
Abstract: | BACKGROUND: The St. Jude Medical Regent valve is the next-generation bileaflet aortic prosthesis, modified from the currently marketed St. Jude Medical mechanical valve to achieve a larger geometric orifice without changing the existing design of the pivot mechanism or blood-contact surface areas. The present study reports the hemodynamic and early clinical results of an ongoing multicenter trial investigating the performance of the Regent valve. METHODS: Between July 1998 and July 2001, 361 patients at 17 centers in North America and Europe underwent implantation of a Regent mechanical aortic valve prosthesis. Clinical status was prospectively recorded, and echocardiography with Doppler was performed at discharge and at 2 months, 6 months, 1 year, and 2 years after operation. RESULTS: Follow-up to date is 300 patient-years (average, 0.8 +/- 0.7 years per patient; range, 0.0 to 2.7 years). There were low rates of clinical adverse events. Mean gradient at 6 months was 9.7 +/- 5.3 mm Hg, 7.6 +/- 5.2 mm Hg, 6.3 +/- 3.7 mm Hg, 5.8 +/- 3.4 mm Hg, and 4.0 +/- 2.6 mm Hg, respectively, for 19-mm, 21-mm, 23-mm, 25-mm, and 27-mm valves; effective orifice area was 1.6 +/- 0.4 cm2, 2.0 +/- 0.7 cm2, 2.2 +/- 0.9 cm2, 2.5 +/- 0.9 cm2, and 3.6 +/- 1.3 cm2, respectively. Indexed effective orifice area was equal to or greater than 1.0 cm2/m2 for all valve sizes. Left ventricular mass index decreased significantly between early postoperative (165.9 +/- 57.1 g/m2) and 6-month follow-up (137.9 +/- 41.0 g/m2; delta = -28.0 +/- 49.1 g/m2; p < 0.0001). CONCLUSIONS: The St. Jude Medical Regent aortic valve has excellent hemodynamics and early clinical results, with rapid and significant left ventricular mass regression. Long-term clinical assessment is ongoing. |
| |
Keywords: | 35Author Keywords: aortic valve operation heart valve prosthesis hemodynamics left ventricular hypertrophy |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|